Trials / Completed
CompletedNCT00590473
Sacral Neuromodulation in Patients With IC
Sacral Neuromodulation: Bilateral Placement vs. Unilateral Placement in Patients With Interstitial Cystitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Drexel University College of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis for this study is that bilateral sacral neuromodulation will improve symptoms of interstitial cystitis by at least 25% when compared to unilateral sacral neuromodulation as reported by patient's responses to the Interstitial Cystitis Symptom and Problem Indices. This study will be a prospective randomized study comparing bilateral to unilateral sacral neuromodulation. The study population will include all patients diagnosed with interstitial cystitis, using the NIDDK criteria, having staged sacral neuromodulator stimulators placed at Hahnemann University Hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Interstim | Unilateral vs. Bilateral Placement of Interstim IPG |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-01-10
- Last updated
- 2017-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00590473. Inclusion in this directory is not an endorsement.